Lv2
150 积分 2021-10-22 加入
Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features
6天前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
17天前
已完结
The present and future of bispecific antibodies for cancer therapy
18天前
已完结
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
1个月前
已完结
Revumenib: a new era in acute leukemia treatment
1个月前
已完结
Advances in menin inhibition in acute myeloid leukemia
1个月前
已完结
皖公网安备34019202002308
